Abstract
Quantitative structure–activity relationship studies have been performed on twenty one β-carboline derivatives to investigate the structural requirements for antitumor activity. The best 2D-QSAR model (r2 = 0.802, F = 24.321, r2se = 0.325) indicated statistical significance and internal predictivity of the developed model shown by the value of cross validated squared correlation coefficient which was 0.724. A five-point pharmacophore hypothesis yielded ligand based pharmacophore 3D-QSAR models with good partial least-square (PLS) statistics results. The training set and test set correlation was characterized by PLS factors (r 2 = 0.842, SD = 0.306, F = 21.3, P = 4.27e -05, Q2 ext = 0.748, RMSE = 0.531, Pearson-R = 0.975). A docking study revealed the binding orientations of DNA intercalates at active site of amino acid residues. The results of 2D-QSAR and 3D-QSAR give detailed structural insights and at the same time highlight the important binding features of novel β-carboline derivatives as antitumor agents.
Keywords: β-carboline, Antitumor, Pharmacophore, 2D-QSAR, 3D-QSAR, Docking.
Letters in Drug Design & Discovery
Title:Pharmacophore Modeling and QSAR Analysis of Novel β-carboline Derivatives as Antitumor Agents
Volume: 10 Issue: 7
Author(s): Ravindra Kumar Chourasiya, A. Raghuram Rao and Ram Kishore Agrawal
Affiliation:
Keywords: β-carboline, Antitumor, Pharmacophore, 2D-QSAR, 3D-QSAR, Docking.
Abstract: Quantitative structure–activity relationship studies have been performed on twenty one β-carboline derivatives to investigate the structural requirements for antitumor activity. The best 2D-QSAR model (r2 = 0.802, F = 24.321, r2se = 0.325) indicated statistical significance and internal predictivity of the developed model shown by the value of cross validated squared correlation coefficient which was 0.724. A five-point pharmacophore hypothesis yielded ligand based pharmacophore 3D-QSAR models with good partial least-square (PLS) statistics results. The training set and test set correlation was characterized by PLS factors (r 2 = 0.842, SD = 0.306, F = 21.3, P = 4.27e -05, Q2 ext = 0.748, RMSE = 0.531, Pearson-R = 0.975). A docking study revealed the binding orientations of DNA intercalates at active site of amino acid residues. The results of 2D-QSAR and 3D-QSAR give detailed structural insights and at the same time highlight the important binding features of novel β-carboline derivatives as antitumor agents.
Export Options
About this article
Cite this article as:
Chourasiya Kumar Ravindra, Rao Raghuram A. and Agrawal Kishore Ram, Pharmacophore Modeling and QSAR Analysis of Novel β-carboline Derivatives as Antitumor Agents, Letters in Drug Design & Discovery 2013; 10 (7) . https://dx.doi.org/10.2174/1570180811310070004
DOI https://dx.doi.org/10.2174/1570180811310070004 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Correlations and Hierarchical Clustering Investigation Between Weather
and SARS-CoV-2
Recent Advances in Computer Science and Communications High Content Pharmacophores from Molecular Fields: A Biologically Relevant Method for Comparing and Understanding Ligands
Current Computer-Aided Drug Design Examining the Causes of Maternal Mortality in Pregnant Women Since the Beginning of the COVID-19 Pandemic in Hamadan Province, Western Iran: A Research Article
Coronaviruses TRPV4 Agonists and Antagonists
Current Topics in Medicinal Chemistry Modulation of Antibiotic Efflux in Bacteria
Current Medicinal Chemistry - Anti-Infective Agents Synthesis and Bioactivities of 2-Azetidinones as Cholesterol Absorption Inhibitors
Letters in Drug Design & Discovery Preface
Current Bioactive Compounds Small Molecule Ligands of the Human Melanocortin-4 Receptor
Current Topics in Medicinal Chemistry Current Discovery Progress of Some Emerging Anti-infective Chalcones: Highlights from 2016 to 2017
Current Drug Discovery Technologies Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management
Current Pharmaceutical Design Association of Genetic Variation with Pneumonia
Current Respiratory Medicine Reviews Molecular Landscape of Lung Epithelium Contributes to High Severity and Comorbidities for COVID-19 and Lung Cancer
Current Cancer Therapy Reviews Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening
Combinatorial Chemistry & High Throughput Screening Drug-drug Interactions of Angiotensin Converting Enzyme Inhibitors Mediated by Metabolizing Enzymes and Transporters
Current Drug Metabolism Class IV Antiarrhythmic Agents: New Compounds Using an Old Strategy
Current Pharmaceutical Design Optimal Oxygen Therapy in the Critically Ill Patient with Respiratory Failure
Current Respiratory Medicine Reviews Urine Cells-derived iPSCs: An Upcoming Frontier in Regenerative Medicine
Current Medicinal Chemistry Advances in Peptide Pharmaceuticals
Current Pharmaceutical Biotechnology Recent Advances on Multivalent Carbon Nanoform-Based Glycoconjugates
Current Medicinal Chemistry A Multi-dimensional Review on Severe Acute Respiratory Syndrome Coronavirus-2
Current Pharmaceutical Biotechnology